VELOXIS PHARMACEUTICALS
LIVE

Serial Number

79103548

Owner

VELOXIS PHARMACEUTICALS A/S

Attorney

Julia Anne Matheson

Filing Date

Jul 7, 2011

Add to watchlist:

No watchlists yet
View on USPTO

VELOXIS PHARMACEUTICALS Trademark

Serial Number: 79103548 • Registration: 4212076

VELOXIS PHARMACEUTICALS is a trademark filed by VELOXIS PHARMACEUTICALS A/S on July 7, 2011. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

VELOXIS PHARMACEUTICALS A/S (27 trademarks)

KOGLE ALLE 4
DK-2970 HORSHOLM , DK

Entity Type: 99

Veloxis Pharmaceuticals, Inc. (13 trademarks)

2000 Regency Parkway,

Entity Type: 99

Trademark Details

Filing Date

July 7, 2011

Registration Date

September 25, 2012

Published for Opposition

July 10, 2012

Goods & Services

Education and training services, namely, arranging and conducting of seminars, workshops, conferences, lectures and congresses, all in the medical, chemical and pharmaceutical fields

[ Treatment of materials, namely, milling, grinding, mixing, compressing, and melting of pharmaceutical, medicinal, biotechnical and bacteriological substances, preparations, formulations and solutions, for use in the pharmaceutical and medical industries ]

Pharmaceutical preparations, namely, immunotherapeutic and immunosuppressive preparations for medical use for treatment of transplant patients; pharmaceutical preparations and drug delivery systems, pharmaceutical modified release systems, and pharmaceutical controlled release systems, comprised of tablets, granules, pills, sachets, powders, capsules, solutions or fluids, all of the above for use in the treatment of [ mental and ] physical disorders, emergencies and traumas, [ aging, allergy and immunology, ] burns, diseases of the heart and blood vessels, [ dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, ] neurological diseases, [ nephrological diseases, diseases in the obstetrical and gynecological field, ] cancer [, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions in the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions and generalized pain ]

[ Consultancy services regarding intellectual property; licensing of intellectual property; medical and pharmaceutical assistance and consultation, including medical and pharmaceutical information services ]

Medical and pharmaceutical assistance and consultation, namely, medical and pharmaceutical information services, namely, providing medical and scientific research information in the field of pharmaceuticals

Scientific and technological services, namely, scientific research, analysis and testing in the field of medical science, pharmacology, biotechnology and bacteriological areas and providing consultation and information relating thereto; design of drug delivery systems for medical use; conducting of tests regarding medical applications; packaging design for others; designing and development of medical equipment; designing pharmaceutical medical preparations; development of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consultation and information thereto; materials testing for the pharmaceutical and medical industries

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 8, 2024 NREP
PARTIAL INVALIDATION PROCESSED BY THE IB
Jul 21, 2023 INNP
INVALIDATION PROCESSED
Jun 14, 2023 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
May 14, 2023 INPR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 21, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 21, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 21, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 21, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 21, 2023 COAR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sep 14, 2022 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Sep 14, 2022 71.P
TEAS SECTION 71 RECEIVED
Sep 12, 2022 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Sep 25, 2021 REM4
CHANGE OF OWNER RECEIVED FROM IB
Sep 18, 2021 CHLD
INTERNATIONAL REGISTRATION RENEWED
Jul 22, 2021 RNWL
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 21, 2021 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Feb 7, 2020 NREP
PARTIAL INVALIDATION PROCESSED BY THE IB
Oct 11, 2019 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 22, 2019 INPS
INVALIDATION PROCESSED
Jun 22, 2019 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
May 29, 2019 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Sep 29, 2018 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Sep 29, 2018 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 27, 2018 APRE
TEAS SECTION 71 & 15 RECEIVED
Sep 24, 2018 ES75
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Sep 17, 2018 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
Aug 3, 2018 CRCV
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 18, 2018 ADCH
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 25, 2017 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jul 21, 2016 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 26, 2015 ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 11, 2014 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 4, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 11, 2013 FICS
FINAL DISPOSITION PROCESSED
Feb 11, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 25, 2012 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 25, 2012 R.PR
NOTIFICATION PROCESSED BY IB
Jul 23, 2012 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 10, 2012 NPUB
PUBLISHED FOR OPPOSITION
Jul 10, 2012 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 20, 2012 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 20, 2012 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 20, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 1, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 31, 2012 CNSA
EXAMINER'S AMENDMENT ENTERED
May 31, 2012 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 31, 2012 GNEN
EXAMINERS AMENDMENT E-MAILED
May 31, 2012 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 31, 2012 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 30, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 30, 2012 CRFA
ASSIGNED TO LIE
May 22, 2012 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 10, 2012 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 10, 2012 TROA
REFUSAL PROCESSED BY IB
Dec 19, 2011 RFNT
REFUSAL PROCESSED BY IB
Nov 27, 2011 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 10, 2011 RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 10, 2011 RFCS
REFUSAL PROCESSED BY MPU
Nov 8, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 8, 2011 RFCR
NON-FINAL ACTION WRITTEN
Nov 7, 2011 CNRT
REFUSAL PROCESSED BY MPU
Nov 3, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 2, 2011 RFCR
NON-FINAL ACTION WRITTEN
Nov 1, 2011 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 1, 2011 MAFR
ASSIGNED TO EXAMINER
Oct 28, 2011 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 28, 2011 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 27, 2011 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 27, 2011 REPR